Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 92, Issue 5, 1995, Pages 1411-1415

  Chambers, Renee ^a   Gillespie, G Yancey ^a   Soroceanu, Liliana ^a   Andreansky, Samita ^a   Chatterjee, Subhendra ^a   Chou, Joany ^b   Roizman, Bernard ^b   Whitley, Richard J ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CHILDREN S HOSPITAL   (United States)

Author keywords

gene therapy; oncolytic viruses; tumor cell targeting

Indexed keywords

ONCOLYTIC VIRUS;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GLIOMA; GLIOMA CELL; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS RECOMBINANT;

ANIMAL; BRAIN NEOPLASMS; GANCICLOVIR; GENE THERAPY; GENETIC ENGINEERING; GLIOMA; HUMAN; IN VITRO; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; SIMPLEXVIRUS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; VIRUS REPLICATION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; MURINAE; RODENTIA; SIMPLEXVIRUS;

EID: 0028931228     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.92.5.1411     Document Type: Article

References (28)